M. Imawari, M. Nagase, I. Yu. Torshin, & O. A. Gromova. (2023). An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis. IRBIS LLC.
Chicago Style (17th ed.) CitationM. Imawari, M. Nagase, I. Yu. Torshin, and O. A. Gromova. An Open-label, Controlled Trial of the Clinical Effects of Laennec® in Patients with Nonalcoholic Steatohepatitis or Cirrhosis. IRBIS LLC, 2023.
MLA (9th ed.) CitationM. Imawari, et al. An Open-label, Controlled Trial of the Clinical Effects of Laennec® in Patients with Nonalcoholic Steatohepatitis or Cirrhosis. IRBIS LLC, 2023.
Warning: These citations may not always be 100% accurate.